Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements

Bone

Volumn 52, Issue 2, 2013, Pages 562-567

  Silva, Henrique C ^a   Pinheiro, Marcelo M ^a   Genaro, Patrícia S ^a   Castro, Charlles H M ^a   Monteiro, Carlos M C ^a   Fonseca, Francisco A H ^a   Szejnfeld, Vera L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone mineral density; Cardiovascular disease; Coronary events; Fracture; Osteoporosis

Indexed keywords

OSTEOPROTEGERIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MASS; BONE METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; DAIRY PRODUCT; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MORPHOMETRICS; OSTEOPENIA; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SPINE FRACTURE; SPINE RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BONE DENSITY; BRAZIL; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; LUMBAR VERTEBRAE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOPOROSIS; OSTEOPROTEGERIN; PREVALENCE; SPINAL FRACTURES;

EID: 84875030857     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.004     Document Type: Article

References (47)

1. Pinheiro M.M., Castro C.M., Szejnfeld V.L. Low femoral bone mineral density and quantitative ultrasound are risk factors for new osteoporotic fracture and total and cardiovascular mortality: a 5-year population-based study of Brazilian elderly Women. J Gerontol A Biol Sci Med Sci 2006, 61A:196-203.
2. den Uyl D., Nurmohamed M.T., van Tuyl L.H.D., Raterman H.G., Lems W.F. (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther 2011, 13(R5):1-19.
3. Gerber Y., Melton L.J., Weston S., Roger V.L. Association between myocardial infarct and fractures: an emerging phenomenon. Circulation 2011, 124:297-303.
4. Anagnostis P., Karagiannis A., Kakafika A.I., Tziomalos K., Athyros V.G., Mikhailidis D.P. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?. Osteoporos Int 2009, 20:197-207.
5. Eastell R., Newman C., Crossman D.C. Cardiovascular disease and bone. Arch Biochem Biophys 2010, 503:78-83.
6. Griffith J.F., Kumta S.M., Huang Y. Hard arteries, weak bones. Skeletal Radiol 2011, 40:517-521.
7. Lancel P., Magne D. Inflammaging: the driving force in osteoporosis. Med Hypotheses 2011, 76:317-321.
8. Persy V., D'Haese P. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 2009, 15:405-416.
9. Khosla S. A shift in calcium. Nat Med 2011, 17:430-431.
10. Manolagas S.C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010, 31:266-300.
11. Dubbert P.M., Carithers T., Sumner A.E., Barbour K.A., Clark B.L., Hall J.E., et al. Obesity, physical inactivity, and risk for cardiovascular disease. Am J Med Sci 2002, 324:116-126.
12. Moayyeri A., Besson H., Luben R.N., Wareham N.J., Khaw K.-T. The association between physical activity in different domains of life and risk of osteoporotic fractures. Bone 2010, 27:693-700.
13. Leistikow B.N. Smoking and ischemic heart disease disparities between studies, genders, times, and socioeconomic strata. J Cardiovasc Transl Res 2009, 2:267-273.
14. Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int 2012; doi:10.1007/s00198-012-1940-y.
15. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.-B., et al. Levels of vitamin D and cardiometabolics disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.
16. van Schoor N.M., Lips P. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011, 25:585-591.
17. Kannel W.B. Hypertension: reflections on risk and prognostication. Med Clin North Am 2009, 93:541-558.
18. Vestergaard P., Rejnmark L., Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009, 84:103-111.
19. Ilomäki J, Hajat A, Kauhanen J, Kurl S, Kaufman JS, Tuomainen T-P, et al. Relationship between alcohol consumption and myocardial infarction among ageing men using a marginal structural model. Eur J Public Health Advance Access published March 11, 2011: 1-7 doi:10.1093/eurpub/ckr013.
20. Maurel D.B., Boisseau N., Benhamou C.L., Jaffre C. Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int 2012, 23:1-16.
21. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222. Emerging Risk Factors Collaboration.
22. Yamaguchi T., Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus. Endocr J 2011, 8:613-624.
23. Mottillo S., Filion K.B., Genest J., Joseph L., Louise Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
24. Nielson C.M., Srikanth P., Orwoll E.S. Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 2012, 27:1-10.
25. Hernández J.L., Olmos J.M., Gonzales-Macías J.G. Metabolic syndrome, fractures and gender. Maturitas 2011, 68:217-223.
26. Magnus J.H., Broussard D.L. Relationship between bone mineral density and myocardial infarction. Osteoporos Int 2005, 16:2053-2062.
27. Collins T.C., Ewing S.K., Diem S.J., Taylor B.C., Orwoll E.S., Cummings S.R., et al. Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation 2009, 119:2305-2312.
28. Sennerby U., Melhus H., Gedebeorg R., Byberg L., Garmo H., Alhborn A., et al. Cardiovascular disease and risk of hip fracture. JAMA 2009, 302:1666-1673.
29. Pouwels S., Lalmohamed A., Leufkens B., de Boer A., Cooper C., van Staa T., et al. Risk of hip/femur fracture after stroke. Stroke 2009, 40:3281-3285.
30. Alberti K.G.M.M., Zimmet P., Shaw J. The metabolic syndrome-new worldwide definition. Lancet 2005, 366:1059-1062. IDF Epidemiology Task Force Consensus Group.
31. O'Neill T.W., Cooper C., Cannata J.B., Diaz Lopez J.B., Hoszowski K., Johnell O., et al. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiol 1994, 23:559-565.
32. Florindo A.A., Latorre M.R., Jaime P.C., Tanaka T., Zerbini C.A. Metodologia para a avaliação da atividade física habitual em homens com 50 anos ou mais. Rev Saude Publica 2004, 38:307-314. [Erratum in: Rev. Saude. Publica. 2009;43:563].
33. Lewiecki E.M., Gordon C.M., Baim S., Leonard M.B., Bishop N.J., Bianchi M.L., et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008, 43:1115-1121.
34. Kelly T.L., Wilson K.E., Heymsfield S.B. Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One 2009, 4:e7038.
35. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 1993, 8:1137-1148.
36. Kauppila L.I., Polak J.F., Cupples L.A., Hannan M.T., Kiel D.P., Wilson P.W. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
37. Pilz S., Tomaschitz A., Drechsler C., Ritz E., Boehm B.O., Grammer T.B., et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010, 31:1591-1598.
38. Rajasree S., Rajpal K., Kartha C.C., Sarma P.S., RamanKutty V., Iyer C.S.P., et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001, 17:567-571.
39. Goliasch G., Blessberger H., Azar D., Heinze G., Wojta J., Bieglmayer C., et al. Markers of bone metabolism in premature myocardial infarction (≤40years of age). Bone 2011, 48:622-626.
40. Venuraju S.M., Yerramasu A., Corder R., Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 2010, 55:2049-2061.
41. Nabipour I., Kalantarhormozi M., Larijani B., Assadi M., Sanjdideh Z. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Metabolism 2010, 59(5):742-747.
42. Vaccarezza M., Bortul R., Fadda R., Zweyer M. Increased OPG expression and impaired OPG/TRAIL ratio in the aorta of diabetic rats. Med Chem 2007, 3(4):387-391.
43. Fahrleitner-Pammer A., Dobnig H., Piswanger-Soelkner C., Bonelli C., Dimai H.-P., Leb G., et al. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. Wien Klin Wochenschr 2003, 115:291-297.
44. Sypniewska G., Sobanska I., Pater A., Kedziora-Kornatowska K., Nowacki W. Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status?. Med Sci Monit 2010, 16:CR96-101.
45. Wang T.K.M., Bolland M.J., van Pelt N.C., Horne A.M., Mason B.H., Ames R.W., et al. Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J Bone Miner Res Dec 2010, 25(12):2777-2785.
46. Lopes J.B., Figueiredo C.P., Caparbo V.F., Takayama L., Menezes P.R., Scazufca M., et al. Osteoporotic fractures in the Brazilian community-dwelling elderly: prevalence and risk factors. J Clin Densitom 2011, 14:359-366.
47. Kendrick J., Kestenbaum B., Chonchol M. Phosphate and cardiovascular disease. Adv Chronic Kidney Dis 2011, 18:113-119.